Re: Bonini et al.: Phase 2 randomized, double-masked, vehicle-controlled trial of recombinant human nerve growth factor for neurotrophic keratitis (Ophthalmology. 2018;125:1332-1343)
- PMID: 30683186
- DOI: 10.1016/j.ophtha.2018.09.017
Re: Bonini et al.: Phase 2 randomized, double-masked, vehicle-controlled trial of recombinant human nerve growth factor for neurotrophic keratitis (Ophthalmology. 2018;125:1332-1343)
Comment in
-
Reply.Ophthalmology. 2019 Feb;126(2):e15-e16. doi: 10.1016/j.ophtha.2018.09.018. Ophthalmology. 2019. PMID: 30683187 No abstract available.
Comment on
-
Phase II Randomized, Double-Masked, Vehicle-Controlled Trial of Recombinant Human Nerve Growth Factor for Neurotrophic Keratitis.Ophthalmology. 2018 Sep;125(9):1332-1343. doi: 10.1016/j.ophtha.2018.02.022. Epub 2018 Apr 10. Ophthalmology. 2018. PMID: 29653858 Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
